The latest RET news and updates
Join the email list.
Subscribe to receive info on unpublished research, current clinical trials, & general RET news.
2023 Happy Lungs Project RET Research Update
Scientific research update: Drs. John Heymach, Alexandre Drilon, and Alexandre Reuben shared the latest progress on their projects aimed at investigating new therapies for RET-inhibitor resistant disease and developing new immunotherapies for RET cancer.
RET positive lung cancer is caused by a rare mutation of the RET gene that causes cancer cells to grow out of control.
This “driver mutation” occurs in about 2% of non-small cell lung cancer patients and is more common among young never-smokers, often the mothers of school-age children.
In many cases, it isn’t diagnosed until after the cancer has spread to other organs throughout the body. The Happy Lungs Project is dedicated to curing this disease.